All In MedTech

FDA Clearance Tracker · P990017-S035

ANCURE ENDOGRAFT SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Sep 10, 2002 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Sep 10, 2002

Approved

Time to decision

26 days

Received Aug 15, 2002. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P990017-S035
Device name
ANCURE ENDOGRAFT SYSTEM
Applicant location
St Paul, MN
Received
Aug 15, 2002
Decided
Sep 10, 2002
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Express GMP Supplement
Original approval
P990017

Device type

Device class
Class III

Every decision under product code MIH

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE TRANSFER OF THE BALLOON CATHETER SUBASSEMBLY TO GUIDANT PUERTO RICO, DURADO, PUERTO RICO.

Source documents

Other decisions for Boston Scientific Corp

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.